首页> 外文期刊>Investigative ophthalmology & visual science >Novel Role of Mitochondrial Matrix Metalloproteinase-2 in the Development of Diabetic Retinopathy
【24h】

Novel Role of Mitochondrial Matrix Metalloproteinase-2 in the Development of Diabetic Retinopathy

机译:线粒体基质金属蛋白酶-2在糖尿病性视网膜病变发展中的新作用。

获取原文
           

摘要

Purpose.: In the pathogenesis of diabetic retinopathy, retinal mitochondria become dysfunctional, their DNA is damaged, and capillary cells undergo accelerated apoptosis. Matrix metalloproteinase-2 (MMP2) becomes activated and proapoptotic, and the therapies that inhibit the development of diabetic retinopathy alleviate MMP2 activation. The authors sought to elucidate the possible mechanism by which activated MMP2 contributes to mitochondrial dysfunction. Methods.: The effect of the regulation of MMP2 on mitochondrial dysfunction and the subcellular localization of the molecular chaperone important for mitochondrial integrity (Hsp60) and gap junction protein connexin 43 were investigated in retinal endothelial cells. The results were confirmed in retinal mitochondria isolated from diabetic mouse overexpressing MnSOD and in the retinas of normal rats that received intravitreal administration of MMP2. Results.: High glucose increased MMP2 and decreased connexin 43 in the mitochondria of retinal endothelial cells. Although the Hsp60 gene transcript was increased, its abundance in the mitochondria was decreased, and its interaction with MMP2 was increased. In mice, the overexpression of MnSOD protected retinal mitochondria from diabetes-induced increases in MMP2 and decreases in Hsp60 and connexin 43. MMP2 administration in normal rats damaged the retinal mitochondria, decreased Hsp60 and connexin 43, and accelerated the apoptosis of retinal capillary cells. Conclusions.: Elevated MMP2 in the mitochondria degrades its membranes by modulating Hsp60 and damaging connexin 43, and this activates the apoptotic machinery. Better understanding of MMP2-mediated mitochondrial damage could help identify new strategies for the treatment of this blinding disease.
机译:目的:在糖尿病性视网膜病的发病机理中,视网膜线粒体功能失调,其DNA受损,毛细血管细胞加速凋亡。基质金属蛋白酶2(MMP2)被激活并凋亡,抑制糖尿病性视网膜病发展的疗法减轻了MMP2的激活。作者试图阐明激活的MMP2导致线粒体功能障碍的可能机制。方法:在视网膜内皮细胞中研究了MMP2调节对线粒体功能障碍的影响以及对线粒体完整性(Hsp60)和间隙连接蛋白连接蛋白43重要的分子伴侣的亚细胞定位。从过量表达MnSOD的糖尿病小鼠的视网膜线粒体以及接受玻璃体内注射MMP2的正常大鼠的视网膜中证实了这一结果。结果:高糖可增加视网膜内皮细胞线粒体中MMP2的含量,并降低连接蛋白43的含量。尽管增加了Hsp60基因的转录本,但其在线粒体中的丰度却降低了,并且与MMP2的相互作用也增加了。在小鼠中,MnSOD的过表达保护了视网膜线粒体,使其免受糖尿病诱导的MMP2的增加以及Hsp60和连接蛋白43的降低。在正常大鼠中施用MMP2会损害视网膜线粒体,降低Hsp60和连接蛋白43,并加速视网膜毛细血管细胞的凋亡。结论:线粒体中MMP2的升高通过调节Hsp60和破坏连接蛋白43来降解其膜,这激活了凋亡机制。更好地了解MMP2介导的线粒体损伤可能有助于确定治疗这种致盲性疾病的新策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号